# Character Biosciences: Biotechnology, San Francisco, United States

> Character Biosciences: Character Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development for...

Source: https://millionrounds.com/startup/character-biosciences (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Character Biosciences

Character Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development for progressive, polygenic diseases, particularly in ophthalmology.

Email

Funding reported Last round: Series A

Biotechnology San Francisco, United States

Follow Character Biosciences and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fcharacter-biosciences)

Company summary

- **Founded:** 2019 7 years old
- **Team:** 59 51 to 200 people
- **Funding reported:** $27M in dollars
- **Last round:** Series A Sept 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Character Biosciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Character Biosciences

Character Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development for progressive, polygenic diseases, particularly in ophthalmology.

Formerly known as Clover Therapeutics, the company utilizes an AI-powered platform that integrates genomics, clinical data, and machine learning to identify genetic and molecular drivers of disease progression. This approach aims to develop targeted therapies for patients with urgent unmet needs. Headquartered in Jersey City, New Jersey, with additional operations in California and Brisbane, Character Biosciences operates a drug discovery platform that partners with over 150 ophthalmology clinics. The company is advancing its lead programs, CTX114 and CTX203, which target dry Age-Related Macular Degeneration (AMD) and Primary Open-Angle Glaucoma (POAG). Both programs are in preclinical stages, aiming to deliver more precise and effective therapies for these conditions. Character Biosciences has raised at least $93 million in Series B funding to support its clinical trial advancements.

## What company datasets say Character Biosciences raised

Funding, as reported

Reported in all **$27M** in dollars

Rounds **4**

Last round **Series A**

Last round size **$110M**

Last round date **Sept 2022**

Investors listed **10**

## On 3 portfolio pages

Investors who name them

- [Innovation Endeavors](https://millionrounds.com/fund/innovation-endeavors)
- [KdT Ventures](https://millionrounds.com/fund/kdt-ventures)
- [Lifeforce Capital](https://millionrounds.com/fund/lifeforce-capital)

Each firm lists Character Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care personalized ophthalmology ai-enabled biomarkers computer & network security information technology & services data security genetic pathways disease subtyping disease progression hospital & health care medical patient stratification therapeutic development health biotechnology retinal imaging biomarkers

Built with from their website

Amazon SES Amazon CloudFront Google Sheets Atlassian Google Cloud Expensify Flow Intel Nios Cloudflare DNS Google Workspace

+8 more

Zoom Meetings Olo CloudFlare Electron Viewport Meta Google Analytics HTTP/3 Amazon Simple Email Service

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** California
- **Revenue:** $1.0M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/character-biosciences)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Character Biosciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)